Weiguo Tan
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
-
- Mycobacterium research and diagnosis
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumonia and Respiratory Infections
Papers in
- Epidemiology 19
- Mycobacterium research and diagnosis 11
- Pneumocystis jirovecii pneumonia detection and treatment 6
- Pneumonia and Respiratory Infections 4
-
- Tuberculosis Research and Epidemiology 16
- Co-authors
- Weiye Yu (9 shared papers)Cheung-Ter Ong (1 shared paper)Qian Gao (8 shared papers)Qingyun Liu (4 shared papers)Qi Jiang (7 shared papers)Zuanguang Chen (1 shared paper)Xing Huang (1 shared paper)Zhaofan Luo (1 shared paper)
- Journals
- Frontiers in Public Health (2 papers)Clinical Infectious Diseases (1 paper)Biotechnology and Applied Biochemistry (1 paper)Infection and Drug Resistance (1 paper)Journal of Clinical Medicine (1 paper)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Weiguo Tan
33 papers receiving 509 citations
Peers
Comparison fields: 5 of 93
- Infectious Diseases 257
- Epidemiology 242
- Toxicology 19
- Pharmaceutical Science 32
- Molecular Medicine 25
Countries citing papers authored by Weiguo Tan
This map shows the geographic impact of Weiguo Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiguo Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiguo Tan more than expected).
Fields of papers citing papers by Weiguo Tan
This network shows the impact of papers produced by Weiguo Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiguo Tan. The network helps show where Weiguo Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiguo Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 60 | |
| 2 | Two years review of cutaneous adverse drug reaction from first line anti-tuberculous drugs. | 2007 | 57 |
| 3 | 2019 | 55 | |
| 4 | 2013 | 52 | |
| 5 | 2018 | 50 | |
| 6 | 2022 | 39 | |
| 7 | 2014 | 27 | |
| 8 | 2021 | 25 | |
| 9 | 2020 | 19 | |
| 10 | 2021 | 14 | |
| 11 | 2021 | 12 | |
| 12 | 2023 | 11 | |
| 13 | 2021 | 10 | |
| 14 | 2022 | 9 | |
| 15 | 2019 | 9 | |
| 16 | 2018 | 8 | |
| 17 | 2018 | 7 | |
| 18 | Hospitalised low-risk community-acquired pneumonia: outcome and potential for cost-savings. | 1999 | 7 |
| 19 | 2019 | 6 | |
| 20 | 2023 | 5 |
About Weiguo Tan
Weiguo Tan is a scholar working on Epidemiology, Infectious Diseases, Surgery, Molecular Biology and Neurology, having authored 33 papers that have together received 517 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (16 papers), Mycobacterium research and diagnosis (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Diagnosis and treatment of tuberculosis (5 papers), Pneumonia and Respiratory Infections (4 papers), Advanced biosensing and bioanalysis techniques (2 papers), Spinal Hematomas and Complications (2 papers) and Infectious Diseases and Tuberculosis (2 papers). The work is most often cited by research in Infectious Diseases (257 citations), Epidemiology (242 citations), Toxicology (19 citations), Pharmaceutical Science (32 citations) and Molecular Medicine (25 citations). Weiguo Tan has collaborated with scholars based in China, United States and France. Frequent co-authors include Weiye Yu, Cheung-Ter Ong, Qian Gao, Qingyun Liu, Qi Jiang, Zuanguang Chen, Xing Huang, Zhaofan Luo, Ningning Li and Howard Takiff. Their work appears in journals such as Frontiers in Public Health, Clinical Infectious Diseases, Biotechnology and Applied Biochemistry, Infection and Drug Resistance and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.